menu
    • menu
    [{"orgOrder":0,"company":"University Hospital, Lille","sponsor":"InBrain Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"FRANCE","productType":"Hormone","year":"2020","type":"Inapplicable","leadProduct":"Dopamine","moa":"Beta-1 adrenergic receptor","graph1":"Neurology","graph2":"Phase I\/ Phase II","graph3":"University Hospital, Lille","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University Hospital, Lille \/ InBrain Pharma","highestDevelopmentStatusID":"7","companyTruncated":"University Hospital, Lille \/ InBrain Pharma"},{"orgOrder":0,"company":"Brepco Biopharma","sponsor":"Piramal Critical Care","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"IRELAND","productType":"Hormone","year":"2025","type":"Inapplicable","leadProduct":"Dopamine","moa":"Beta-1 adrenergic receptor","graph1":"Cardiology\/Vascular Diseases","graph2":"Approved FDF","graph3":"Brepco Biopharma","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Brepco Biopharma \/ Piramal Critical Care","highestDevelopmentStatusID":"15","companyTruncated":"Brepco Biopharma \/ Piramal Critical Care"},{"orgOrder":0,"company":"University College Cork","sponsor":"Cork University Hospital | Coombe Women and Infants University Hospital | Royal College of Surgeons, Ireland | National Maternity Hospital, Ireland | University Hospital Antwerp | KU Leuven | University of Alberta | CHU Sainte-Justine | Institute for the ","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"IRELAND","productType":"Hormone","year":"2011","type":"Inapplicable","leadProduct":"Dopamine","moa":"Beta-1 adrenergic receptor","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"University College Cork","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University College Cork \/ Cork University Hospital | Coombe Women and Infants University Hospital | Royal College of Surgeons, Ireland | National Maternity Hospital, Ireland | University Hospital Antwerp | KU Leuven | University of Alberta | CHU Sainte-Justine | Institute for the ","highestDevelopmentStatusID":"10","companyTruncated":"University College Cork \/ Cork University Hospital | Coombe Women and Infants University Hospital | Royal College of Surgeons, Ireland | National Maternity Hospital, Ireland | University Hospital Antwerp | KU Leuven | University of Alberta | CHU Sainte-Justine | Institute for the "},{"orgOrder":0,"company":"University Hospital, Lille","sponsor":"InBrain Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"FRANCE","productType":"Hormone","year":"2025","type":"Inapplicable","leadProduct":"Dopamine","moa":"Beta-1 adrenergic receptor","graph1":"Neurology","graph2":"Phase I\/ Phase II","graph3":"University Hospital, Lille","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"University Hospital, Lille \/ InBrain Pharma","highestDevelopmentStatusID":"7","companyTruncated":"University Hospital, Lille \/ InBrain Pharma"}]

    Find Clinical Drug Pipeline Developments & Deals for Dopamine hydrochloride in dextrose 5% in plastic container

    Menu

    Dopamine hydrochloride in dextrose 5% in plastic container

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University Hospital, Lille

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            University Hospital, Lille

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Neurology

                            Study Phase : Phase I/ Phase II

                            Sponsor : InBrain Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopam...

                            Details : Dopamine is a Hormone drug candidate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of Parkinson Disease.

                            Product Name : Undisclosed

                            Product Type : Hormone

                            Upfront Cash : Inapplicable

                            October 09, 2025

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : InBrain Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Brepco Biopharma

                            Ireland arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Brepco Biopharma

                            Ireland arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Approved FDF

                            Sponsor : Piramal Critical Care

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            BrePco Biopharma and Piramal Critical Care Announce MHRA Approval for Neoatricon in UK

                            Details : Neoatricon (dopamine hydrochloride) is a Beta-1 adrenergic receptor stimulator, small molecule drug candidate, which is indicated for the treatment of hypotension.

                            Product Name : Neoatricon

                            Product Type : Hormone

                            Upfront Cash : Inapplicable

                            March 21, 2025

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Approved FDF

                            Sponsor : Piramal Critical Care

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            University Hospital, Lille

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            University Hospital, Lille

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Neurology

                            Study Phase : Phase I/ Phase II

                            Sponsor : InBrain Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Dopaminergic RestauratIon by IntraVEntriculaire Administration

                            Details : Dopamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Parkinson Disease.

                            Product Name : Undisclosed

                            Product Type : Hormone

                            Upfront Cash : Inapplicable

                            April 02, 2020

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : InBrain Pharma

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            University College Cork

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            University College Cork

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Phase III

                            Sponsor : Cork University Hospital | Coombe Women and Infants University Hospital | Royal College of Surgeons, Ireland | National Maternity Hospital, Ireland | University Hospital Antwerp | KU Leuven | University of Alberta | CHU Sainte-Justine | Institute for the

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Management of Hypotension In the Preterm Infant

                            Details : Dopamine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypotension.

                            Product Name : Undisclosed

                            Product Type : Hormone

                            Upfront Cash : Inapplicable

                            November 30, 2011

                            Lead Product(s) : Dopamine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Phase III

                            Sponsor : Cork University Hospital | Coombe Women and Infants University Hospital | Royal College of Surgeons, Ireland | National Maternity Hospital, Ireland | University Hospital Antwerp | KU Leuven | University of Alberta | CHU Sainte-Justine | Institute for the

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth